Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

DXY Completes $100 Million Series D Round for Academic Portal for China Doctors

publication date: Apr 10, 2018

DXY, the online academic portal for doctors and other life science professionals, raised $100 million in a Series D funding from undisclosed investors. According to China Money Network, the funding was conducted at a $1 billion-plus valuation, conferring Unicorn status on DXY. The eighteen-year-old site provides China doctors with up-to-date clinical and research information, as well as information about conferences, jobs and other services. DXY is also China's largest e-marketing platform for life science companies. It features academic discussions, medical information, job opportunities and medical news. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital